[unable to retrieve full-text content]The Big 3 PBMs are Countersuing the FTC. Does Their Argument Have Any Teeth? MedCity News After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of anticompetitive rebating practices related to insulin, the defendants reversed roles and became plaintiffs. In November, they countersued the agency, arguing that its lawsuit […] The post PBMs Countersue FTC appeared first on Angry Bear.
Read More »